InterventionsReview
Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis
The Orthopedic Clinics of North America
- GLP-1 receptor agonists
- Extracellular matrix remodelling
- GLP-1 and incretin signalling
- Osteoarthritis
- Inflammatory arthritis
- Humans
The paper
Trudeau M, Schaffer O, Schwarzkopf R
The Orthopedic Clinics of North America · 23 Jul 2026
